Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Score an Extra 655% with EKSO – Make Your Move Now

From the first moment it came to my attention, I've been as consistent as I have been emphatic – EKSO Bionics Holdings Inc. (OTCBB: EKSO) is a "buy" despite volatility and price drift in recent months that have given many investors pause. There are two reasons why:

1. It's entirely normal for a company Ekso's size.

2. The company has continued to expand market share that will ultimately translate into higher earnings and share price.
Now there's a third.

If you don't get into the stock now, you could lose the "first mover" advantage that you've had so far. Worse, you could miss out on another double – Ekso's second since I recommended it.

You see, EKSO's just hit a landmark that tells me the incredible growth potential we've had to ourselves won't be a secret for much longer.

Analysts Couldn't Ignore This Earnings Report

EKSOOnce you've learned how to do it correctly (like we're doing together), evaluating a company for investment potential isn't rocket science. There are usually any number of things that point to a bright future including savvy management, a clear vision, an awesome product, conservative positioning, and consistency.

Really taking things to the next level, though, requires something else – fabulous earnings. That's because they're the ultimate litmus test when it comes to potential.

Take EKSO's latest quarterly earnings report, for example. The company announced on March 17 that total revenue for the fourth quarter of 2014 was $1.5 million, up 87.5% from the $0.8 million achieved in Q4/2013.

For most small companies, this is usually a one-and-done phenomenon, meaning that they have great numbers for a quarter or two and only in one segment of the business. They try to be all things to all people, so they wind up overextending and, more often than not, falling apart, taking their investors to the poor house.

The real winners, though, usually have great specificity and a narrow product/market concentration. So you see those gains translate into a broad base at every level of operations. This is where EKSO stands out…

Join the conversation. Click here to jump to comments…

About the Author

Keith Fitz-Gerald has been the Chief Investment Strategist for the Money Morning team since 2007. He's a seasoned market analyst with decades of experience, and a highly accurate track record. Keith regularly travels the world in search of investment opportunities others don't yet see or understand. In addition to heading The Money Map Report, Keith runs High Velocity Profits, which aims to get in, target gains, and get out clean. In his weekly Total Wealth, Keith has broken down his 30-plus years of success into three parts: Trends, Risk Assessment, and Tactics – meaning the exact techniques for making money. Sign up is free at totalwealthresearch.com.

Read full bio

  1. Michael Bush | April 4, 2015

    Keith:
    On Wednesday I instructed my broker to purchase an additional 500 shares of ESKO at 2.09. He told me that a restriction had been Placed on the stock and he could not purchase it for me. Can you explain why the restriction occurred and how would I need to do or how the broker can help me acquire these additional shares.

    Regards:

    Mike Bush
    The small investor

  2. tony bright | April 11, 2015

    Please i am in Ghana so how can i join in to acsuire some shares

  3. SASSON S. | April 22, 2015

    ekso is down 10% it it going to rebound ?

  4. David Zeiler | June 3, 2015

    Here's a link to Keith's response regarding EKSO (on his Total Wealth Research website):
    http://totalwealthresearch.com/2015/06/how-to-handle-a-short-attack-on-a-stock-you-own/

Leave a Reply

Your email address will not be published. Required fields are marked *

Some HTML is OK